Related Experiment Video
Updated: Nov 1, 2025
06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
7.0K
Thrombin: A Pivotal Player in Hemostasis and Beyond
Julie Brogaard Larsen1, Anne-Mette Hvas1,2
1Department of Clinical Biochemistry, Thrombosis and Hemostasis Research Unit, Aarhus University Hospital, Aarhus, Denmark.
Seminars in Thrombosis and Hemostasis
|June 21, 2021
Summary
Thrombin, crucial for blood clotting, also impacts inflammation and tumor growth. Measuring thrombin generation offers insights into bleeding disorders and clot risks.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Thrombin, a serine protease, is central to hemostasis, regulating fibrin formation and clot stabilization.
- Beyond coagulation, thrombin influences endothelium, inflammation, angiogenesis, and tumor progression.
- Thrombin's short half-life and rapid inhibition necessitate indirect measurement of its generation.
Purpose of the Study:
- To review thrombin's structure and mechanisms in physiological and pathological contexts.
- To summarize laboratory assays for measuring thrombin generation in vivo and ex vivo.
- To discuss the clinical utility of thrombin generation biomarkers in various patient populations.
Main Methods:
- Literature review of thrombin's role in hemostasis and beyond.
- Analysis of laboratory methods for assessing thrombin generation.
- Synthesis of data on biomarker applications in clinical settings.
Main Results:
- Thrombin exhibits diverse roles, extending beyond its hemostatic functions.
- Various assays exist to measure thrombin generation, reflecting its complex activity.
- Thrombin generation biomarkers show potential in assessing bleeding disorders, bypass surgery, and thromboembolic risk.
Conclusions:
- Understanding thrombin's multifaceted roles is essential for comprehending its physiological and pathological significance.
- Thrombin generation assays provide valuable insights into coagulation dynamics.
- Further research and clinical application of these biomarkers hold promise for improved patient management.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.4K
01:16Clot Retraction and Fibrinolysis
7.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.6K
01:09Coagulation
8.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.6K
01:06Coagulation
528
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
528
01:05Introduction to Hemostasis
10.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
10.6K